Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
22 April 2024
|
|
m 23:12 | Multiple myeloma - historical 3 changes history +20 [Jwarner (3×)] | |||
| m |
|
23:12 (cur | prev) +7 Jwarner talk contribs →Preceding treatment | |||
| m |
|
23:11 (cur | prev) +6 Jwarner talk contribs | |||
| m |
|
23:10 (cur | prev) +7 Jwarner talk contribs →Subsequent treatment | |||
21 April 2024
| m 12:48 | Breast cancer - historical diffhist +12 Jwarner talk contribs | ||||
| m 12:42 | Acute myeloid leukemia - historical diffhist +12 Jwarner talk contribs →DAT {{#subobject:fc4f58|Regimen=1}} | ||||
20 April 2024
|
|
m 20:06 | Breast cancer - historical 9 changes history +1,397 [Jwarner (9×)] | |||
| m |
|
20:06 (cur | prev) +1,560 Jwarner talk contribs →STAMP-I {{#subobject:c08ab4|Regimen=1}} | |||
| m |
|
20:05 (cur | prev) -1,561 Jwarner talk contribs →VAP {{#subobject:4b99b8|Regimen=1}} | |||
| m |
|
20:04 (cur | prev) +513 Jwarner talk contribs →CTCb, then auto HSCT {{#subobject:02f569|Regimen=1}} | |||
| m |
|
19:55 (cur | prev) +2,042 Jwarner talk contribs →CHUT, then auto HSCT {{#subobject:e9e363|Regimen=1}} | |||
| m |
|
19:55 (cur | prev) -2,042 Jwarner talk contribs →CTCb, then auto HSCT {{#subobject:02f569|Regimen=1}} | |||
| m |
|
19:54 (cur | prev) +2,013 Jwarner talk contribs →CHUT, then auto HSCT {{#subobject:e9e363|Regimen=1}} | |||
| m |
|
19:53 (cur | prev) +1,366 Jwarner talk contribs →Mitoxantrone & Vinorelbine (MV) {{#subobject:eb48ba|Regimen=1}} | |||
| m |
|
19:50 (cur | prev) -2,555 Jwarner talk contribs →STAMP-I {{#subobject:c08ab4|Regimen=1}} | |||
| m |
|
19:47 (cur | prev) +61 Jwarner talk contribs →Metastatic disease, first-line therapy | |||